CG Oncology Inc.(CGON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CGON CG Oncology Inc.

Closed Martin Luther King, Jr. Day 01-16 16:00:00 EST

54.73

+1.66

+3.13%

盘后54.60

-0.13-0.24%

17:22 EST

High55.17	Low52.17	Vol1.05M
Open53.20	D1 Closing53.07	Amplitude5.65%
Mkt Cap4.41B	Tradable Cap3.58B	Total Shares80.67M
T/O57.29M	T/O Rate1.61%	Tradable Shares65.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":54.73,"timestamp":1768597200000,"preClose":53.07,"halted":0,"volume":1054478,"hourTrading":{"tag":"盘后","latestPrice":54.6,"preClose":54.73,"latestTime":"17:22 EST","volume":79689,"amount":4361364.97,"timestamp":1768602173747,"change":-0.13,"changeRate":-0.002375,"amplitude":0},"delay":0,"changeRate":0.03127944224609001,"floatShares":65435300,"shares":80666179,"eps":-1.935,"marketStatus":"Closed Martin Luther King, Jr. Day","change":1.66,"latestTime":"01-16 16:00:00 EST","open":53.2,"high":55.17,"low":52.17,"amount":57291708.88996,"amplitude":0.056529,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.935,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":53.07,"preHourTrading":{"tag":"盘前","latestPrice":53.18,"preClose":53.07,"latestTime":"09:29 EST","volume":3735,"amount":199429.578,"timestamp":1768573799999,"change":0.11,"changeRate":0.002073,"amplitude":0.01677},"postHourTrading":{"tag":"盘后","latestPrice":54.6,"preClose":54.73,"latestTime":"17:22 EST","volume":79689,"amount":4361364.97,"timestamp":1768602173747,"change":-0.13,"changeRate":-0.002375,"amplitude":0},"volumeRatio":0.4480762107995657,"impliedVol":0.6962,"impliedVolPercentile":0.6375},"requestUrl":"/m/hq/s/CGON/wiki","defaultTab":"wiki","newsList":[{"id":"2604990651","title":"CG Oncology Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2604990651","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604990651?lang=en_us&edition=fundamental","pubTime":"2026-01-17 00:23","pubTimestamp":1768580580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 16, 2026 11:23 ET (16:23 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"gpt_icon":0},{"id":"2603599877","title":"CG Oncology price target raised to $70 from $55 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2603599877","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603599877?lang=en_us&edition=fundamental","pubTime":"2026-01-16 20:01","pubTimestamp":1768564885,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Kelsey Goodwin raised the firm’s price target on CG Oncology (CGON) to $70 from $55 and keeps an Overweight rating on the sha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-70-from-55-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-70-from-55-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","CG"],"gpt_icon":0},{"id":"2603655868","title":"CG Oncology Expands At-The-Market Equity Offering Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2603655868","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603655868?lang=en_us&edition=fundamental","pubTime":"2026-01-14 06:17","pubTimestamp":1768342678,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc. ( ($CGON) ) has provided an update. On January 13, 2026, CG Oncology, Inc. filed an amended prospectus with the U.S. Securities a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cg-oncology-expands-at-the-market-equity-offering-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cg-oncology-expands-at-the-market-equity-offering-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","IE00B64PRP62.GBP","CGON","EQR","IE00B3QW5Z07.USD","BK4585","BK4215","IE00BGHQF748.EUR","BK4139","BK4135","BK4588"],"gpt_icon":0},{"id":"2603535686","title":"CG Oncology Inc Files for Offering of up to $550 Mln Common Stock  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603535686","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603535686?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:50","pubTimestamp":1768341011,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE16V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2603265832","title":"CG Oncology Director James Mulay Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603265832","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603265832?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:15","pubTimestamp":1768338947,"startTime":"0","endTime":"0","summary":"James Mulay, Director at CG Oncology Inc., reported a disposal of common shares of CG Oncology Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDLc3cC3w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CG Oncology Director James Mulay Reports Disposal of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2603542910","title":"CG Oncology Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542910","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603542910?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:42","pubTimestamp":1768236120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 12, 2026 11:42 ET (16:42 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"gpt_icon":0},{"id":"2602288511","title":"Wedbush Raises Price Target on CG Oncology to $77 From $70, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2602288511","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602288511?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:46","pubTimestamp":1768218404,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) has an average rating of buy and mean price target of $76.57, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","CGON"],"gpt_icon":0},{"id":"2602347845","title":"Assessing CG Oncology (CGON) Valuation After Strong Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2602347845","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602347845?lang=en_us&edition=fundamental","pubTime":"2026-01-11 07:26","pubTimestamp":1768087595,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) has drawn attention after recent share price moves, with the stock last closing at US$54.20. Investors are weighing that level against the company’s current fundamentals and recent clinical progress.\nSee our latest analysis for CG Oncology.\nThe latest move sits on top of strong recent momentum, with a 1 day share price return of 29.26%, a 30 day share price return of 29.85% and a 1 year total shareholder return of 79.47%. Together, these figures suggest that investors are...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/assessing-cg-oncology-cgon-valuation-after-strong-recent-sha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/assessing-cg-oncology-cgon-valuation-after-strong-recent-sha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","CG","DCF","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","CGON","BK4135"],"gpt_icon":0},{"id":"2602061293","title":"Accelerated Creto Trajectory in NMIBC Drives Earlier Data, De-Risked Commercialization, and Higher $66 Target Supporting Buy Rating on CG Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2602061293","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602061293?lang=en_us&edition=fundamental","pubTime":"2026-01-10 03:55","pubTimestamp":1767988521,"startTime":"0","endTime":"0","summary":"Gregory Renza, an analyst from Truist Financial, maintained the Buy rating on CG Oncology, Inc.. The associated price target was raised to $66.00. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/accelerated-creto-trajectory-in-nmibc-drives-earlier-data-de-risked-commercialization-and-higher-66-target-supporting-buy-rating-on-cg-oncology-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/accelerated-creto-trajectory-in-nmibc-drives-earlier-data-de-risked-commercialization-and-higher-66-target-supporting-buy-rating-on-cg-oncology-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","CGON"],"gpt_icon":0},{"id":"2602130645","title":"CG Oncology price target raised to $66 from $62 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2602130645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602130645?lang=en_us&edition=fundamental","pubTime":"2026-01-10 03:50","pubTimestamp":1767988231,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on CG Oncology (CGON) to $66 from $62 and keeps a Buy rating on the shares after the company provided an upda...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-66-from-62-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-66-from-62-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","CGON"],"gpt_icon":0},{"id":"2602459306","title":"CG Oncology price target raised to $93 from $89 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2602459306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602459306?lang=en_us&edition=fundamental","pubTime":"2026-01-10 03:50","pubTimestamp":1767988214,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on CG Oncology (CGON) to $93 from $89 and keeps an Overweight rating on the shares after the company ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-93-from-89-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-93-from-89-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","CGON"],"gpt_icon":0},{"id":"2602305749","title":"CG Oncology Up Over 27%, on Track for Record High Close and Record Percent Increase -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2602305749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602305749?lang=en_us&edition=fundamental","pubTime":"2026-01-10 03:16","pubTimestamp":1767986160,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc.  is currently at $53.40, up $11.47 or 27.35%. --Up 27.78% this week; best weekly performance since the week ending May 2, 2025, when it rose 29.86%. --Up 76.82% from 52 weeks ago , when it closed at $30.20. --Up 242.52% from its 52-week closing low of $15.59 on April 8, 2025. --Traded as high as $57.40; new all-time intraday high . --Up 36.88% at today's intraday high; largest intraday percent increase since April 28, 2025, when it rose as much as 44.39%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4139","IE00B64PRP62.GBP","CG","CGON","IE00B3QW5Z07.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2602087053","title":"Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January","url":"https://stock-news.laohu8.com/highlight/detail?id=2602087053","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602087053?lang=en_us&edition=fundamental","pubTime":"2026-01-10 01:21","pubTimestamp":1767979285,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/01/49818860/crude-oil-rises-sharply-us-consumer-sentiment-edges-higher-in-january","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139","NVIW.SI","QID","USAW.SI","BBNX","NQmain","ANPA","BK4082","TQQQ","PCRX","SQQQ","USJW.SI",".IXIC","AQST","MNQmain","TSYW.SI","BK4121","PSQ","BK4087","QLD","QTRX","BK4007"],"gpt_icon":1},{"id":"2602370088","title":"CG Oncology, Rich Sparkle Holdings, Liquidia And Other Big Stocks Moving Higher On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2602370088","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602370088?lang=en_us&edition=fundamental","pubTime":"2026-01-10 00:25","pubTimestamp":1767975900,"startTime":"0","endTime":"0","summary":"U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Friday.Shares of CG Oncology Inc  rose sharply during Friday's session after the company announced an expedited timeline for the topline data readout now expected in the first half of 2026 for the Phase 3 PIVOT-006 clinical trial comparing adjuvant intravesical cretostimogene grenadenorepvec versus surveillance in patients with intermediate-risk non-muscle invasive bladder cancer.CG Oncology shares jumped 21.8% to $51.05 on Friday.Here are some other big stocks recording gains in today’s session.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/09/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/09/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/01/49816946/cg-oncology-rich-sparkle-holdings-liquidia-and-other-big-stocks-moving-higher-on-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/01/49816946/cg-oncology-rich-sparkle-holdings-liquidia-and-other-big-stocks-moving-higher-on-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["CG","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4139","CGON","IE00B64PRP62.GBP","BK4135"],"gpt_icon":0},{"id":"2602370157","title":"CG Oncology: Early PIVOT-006 Readout, Strengthened Creto Outlook, and 2026 Catalyst Wave Support Buy Rating and Higher $85 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2602370157","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602370157?lang=en_us&edition=fundamental","pubTime":"2026-01-10 00:05","pubTimestamp":1767974751,"startTime":"0","endTime":"0","summary":"Analyst Soumit Roy from JonesTrading reiterated a Buy rating on CG Oncology, Inc. and increased the price target to $85.00 from $75.00. Soumit Roy ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cg-oncology-early-pivot-006-readout-strengthened-creto-outlook-and-2026-catalyst-wave-support-buy-rating-and-higher-85-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cg-oncology-early-pivot-006-readout-strengthened-creto-outlook-and-2026-catalyst-wave-support-buy-rating-and-higher-85-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","CG"],"gpt_icon":0},{"id":"2602048372","title":"CG Oncology rises 16.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602048372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602048372?lang=en_us&edition=fundamental","pubTime":"2026-01-09 23:00","pubTimestamp":1767970815,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) is up 16.0%, or $6.70 to $48.63. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-rises-16-0-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-rises-16-0-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","IE00BGHQF748.EUR","CG","IE00B3QW5Z07.USD","BK4139","IE00B64PRP62.GBP","BK4135"],"gpt_icon":0},{"id":"2602371067","title":"CG Oncology Accelerates Phase 3 Bladder Cancer Trial Timeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2602371067","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602371067?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:19","pubTimestamp":1767968383,"startTime":"0","endTime":"0","summary":"The latest announcement is out from CG Oncology, Inc. ( ($CGON) ). On January 9, 2026, CG Oncology announced that topline data from its Phase 3 PIV...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cg-oncology-accelerates-phase-3-bladder-cancer-trial-timeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cg-oncology-accelerates-phase-3-bladder-cancer-trial-timeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00B3QW5Z07.USD","CGON","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4135","CG"],"gpt_icon":0},{"id":"2602371602","title":"BRIEF-Cg Oncology Provides Updated Timeline For Pivot-006 Phase 3 Topline Data In Intermediate-Risk Nmibc","url":"https://stock-news.laohu8.com/highlight/detail?id=2602371602","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602371602?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:06","pubTimestamp":1767967608,"startTime":"0","endTime":"0","summary":"BRIEF-Cg Oncology Provides Updated Timeline For Pivot-006 Phase 3 Topline Data In Intermediate-Risk NmibcJan 9 (Reuters) - CG Oncology Inc CGON.O:CG ONCOLOGY PROVIDES UPDATED TIMELINE FOR PIVOT-006 PH","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nTUA9MH8SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2602797163","title":"CG Oncology to Share Data for Investigational Bladder Cancer Therapy Nearly a Year Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2602797163","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602797163?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:57","pubTimestamp":1767967035,"startTime":"0","endTime":"0","summary":"CG Oncology  said Friday it has sped up the timeline for the topline data readout of the phase 3 clinical trial of adjuvant intravesical cretostimogene grenadenorepvec versus surveillance in patients with intermediate-risk non-muscle invasive bladder cancer to H1 2026, nearly a year ahead of schedule because of early enrollment of 360 patients.Chairman and Chief Executive Arthur Kuan said the company hopes to bring forward a potential indication for cretostimogene,  an investigational immunotherapy, as a treatment for non-muscle bladder cancer.Shares of the company were up over 6% in recent premarket activity Friday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4135","IE00BGHQF748.EUR","BK4139","CGON"],"gpt_icon":0},{"id":"2602937602","title":"CG Oncology to Report PIVOT-006 Phase 3 Topline Data for Intermediate-Risk NMIBC in First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602937602","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602937602?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:30","pubTimestamp":1767965425,"startTime":"0","endTime":"0","summary":"CG Oncology Inc. has announced an expedited timeline for the topline data readout of its Phase 3 PIVOT-006 clinical trial. The study evaluates adjuvant intravesical cretostimogene grenadenorepvec versus surveillance in patients with intermediate-risk non-muscle invasive bladder cancer . Topline data from this randomized, open-label registrational trial are now expected in the first half of 2026, nearly one year ahead of schedule due to rapid enrollment across more than 90 sites. The results have not yet been presented and will be available in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via GlobeNewswire  on January 09, 2026, and is solely re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDLb3KHRk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NDAQ","SG9999014039.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014021.USD","CGON","SG9999014013.SGD","BK4112","BK4585","BK4139","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","SG9999014005.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://cgoncology.com","stockEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":0.4645},{"period":"3month","weight":0.3201},{"period":"6month","weight":1.046},{"period":"1year","weight":0.8808},{"period":"ytd","weight":0.3182}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"CG Oncology Inc.","nameEN":"CG Oncology Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CG Oncology Inc.(CGON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CG Oncology Inc.(CGON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CG Oncology Inc.,CGON,CG Oncology Inc.股票,CG Oncology Inc.股票老虎,CG Oncology Inc.股票老虎国际,CG Oncology Inc.行情,CG Oncology Inc.股票行情,CG Oncology Inc.股价,CG Oncology Inc.股市,CG Oncology Inc.股票价格,CG Oncology Inc.股票交易,CG Oncology Inc.股票购买,CG Oncology Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CG Oncology Inc.(CGON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CG Oncology Inc.(CGON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}